Cargando…
Should persons with autosomal dominant AD be included in clinical trials? Authors' response
Autores principales: | Szigeti, Kinga, Doody, Rachelle S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226308/ https://www.ncbi.nlm.nih.gov/pubmed/21631907 http://dx.doi.org/10.1186/alzrt81 |
Ejemplares similares
-
Should persons with autosomal dominant AD be included in clinical trials?
por: Grill, Joshua D, et al.
Publicado: (2011) -
Should EOAD patients be included in clinical trials?
por: Szigeti, Kinga, et al.
Publicado: (2011) -
Cerebral Microbleeds in Autosomal Dominant Polycystic Kidney Disease
por: Tsai, Li-Kai, et al.
Publicado: (2020) -
Autosomal dominant optic atrophy and cataract “plus” phenotype including axonal neuropathy
por: Horga, Alejandro, et al.
Publicado: (2019) -
Should we screen for intracranial aneurysms in children with autosomal dominant polycystic kidney disease?
por: Walker, Emma Y. X., et al.
Publicado: (2022)